[1]
Michaelis, M. et al. 2014. Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function. Journal of Pharmacy & Pharmaceutical Sciences. 17, 1 (Apr. 2014), 154–168. DOI:https://doi.org/10.18433/J3TW24.